Kestra Advisory Services »

Crinetics Pharmaceuticals In shares owned by Kestra Advisory Services

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Kestra Advisory Services from 13F filings

Historical chart of Kestra Advisory Services investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by Kestra Advisory Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by Kestra Advisory Services

Quarter filed Position value Share count Share price at filing
2024-09-30 $261k 5.1k 51.10
2024-06-30 $228k 5.1k 44.79
2023-12-31 $263k 7.4k 35.58
2023-09-30 $221k 7.4k 29.74

More positions owned by Kestra Advisory Services

Apple (AAPL)
Parker-Hannifin Corporation (PH)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Value Etf (VTV)
First Tr Exchange-traded Risng Divd Achiv (RDVY)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)

View all positions for Kestra Advisory Services

Top funds holding Crinetics Pharmaceuticals In

BlackRock
BlackRock
Driehaus Capital Management
T. Rowe Price Associates
Vanguard Group
EcoR1 Capital
State Street Corporation
Jennison Associates
Paradigm Biocapital Advisors
Henderson Group
Point72 Asset Management
Geode Capital Management
Franklin Resources
Cormorant Asset Management
Siren

View all funds holding Crinetics Pharmaceuticals In